Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Completed 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 1

Conditions

Breast Neoplasms 74Carcinoma, Intraductal, Noninfiltrating 11Breast Carcinoma In Situ 9Breast Neoplasms, Male 8Carcinoma, Ductal, Breast 5Inflammatory Breast Neoplasms 4Depression 3Carcinoma, Lobular 3Triple Negative Breast Neoplasms 2Radiation Injuries 2Colorectal Neoplasms 2Colonic Neoplasms 2Skin Abnormalities 1Recurrence 1Pain 1Paget's Disease, Mammary 1Neoplasm Metastasis 1Melanoma 1Malnutrition 1Infertility 1Hot Flashes 1HER2 Negative Breast Cancer 1Fatigue 1Endometrial Neoplasms 1Drug-Related Side Effects and Adverse Reactions 1Cardiotoxicity 1

Interventions

Therapeutics 2Psychiatric Rehabilitation 2Letrozole 2Goserelin 2Cyclophosphamide 2Tamoxifen 1Neoadjuvant Therapy 1Chemotherapy, Adjuvant 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Infertility × Chemotherapy, Adjuvant × Breast × Clear all
NCT00427245 2013-08-07

Goserelin in Preventing Early Menopause in Premenopausal Women Undergoing Chemotherapy for Stage I, Stage II, or Stage III Breast Cancer

National Cancer Institute (NCI)

Phase 3 Completed
400 enrolled
Breast

Breast Neoplasms, Infertility

Data powered by HemOnc (CC BY 4.0) Colophon âš¡